低强度和无化疗治疗在Ph+ALL:基于间接比较的无进展生存率
Melania Rivano1, Daniele Mengato2, Marco Chiumente3
1Binaghi Hospital, 09126 Cagliari, Italy.
Hematology reports
|December 22, 2023
概括
结合blinatumomab和氨酸激酶抑制剂 (TKIs) 的无化疗方案显示,费城染色体阳性B细胞急性淋巴细胞白血病 (Ph+ ALL) 的无进展生存率 (PFS) 优越. 其他基于TKI的治疗方法也显示出显著的疗效差异.
科学领域:
- 血液学 血液学 血液学
- 在瘤学瘤学.
- 人工智能在医学中的应用
背景情况:
- 费城染色体阳性B细胞急性淋巴细胞白血病 (Ph+ ALL) 是一个独特的亚型.
- 低强度和无化疗方案正在成为Ph+ALL的有效治疗选择.
研究的目的:
- 为了比较不同低强度和无化疗治疗方案对Ph+ALL的疗效.
- 为了评估氨酸激酶抑制剂 (TKI) 与化疗相结合,与类固醇结合的TKI,以及布利纳图莫马布加TKI.
主要方法:
- 利用一种人工智能技术Shiny方法,从八项试验的Kaplan-Meier曲线中重建患者级数据.
- 通过使用标准生存统计和间接的头对头比较,分析了无进展生存 (PFS).
- 汇集了来自432名重建患者的数据,分为三个治疗类别:TKICHE,TKISTE和TKIBLI.
主要成果:
- 布利纳马布加上TKIs (TKIBLI) 的无化疗组合显示出最好的PFS.
- 基于技术知识的治疗与低强度化疗 (TKICHE) 结合,排名第二.
- 与类固醇和无化疗相关的TKIs (TKISTE) 显示出最不有利的PFS.
- 在这三种疗法之间观察到PFS的统计学上显著差异.
结论:
- 无化疗的blinatumomab加TKI组合是Ph+ALL的高度有效的治疗策略.
- 闪亮的方法提供了一个强大的方法来合成来自多个试验的证据,并比较治疗疗效.
- 进一步研究优化无化疗和低强度疗法对Ph + ALL的治疗是有必要的.
关键词:
急性淋巴细胞白血病急性淋巴细胞白血病这就是Blinatumomabomab.没有化疗的化学疗法.达沙替尼:尼洛丁尼的使用.伊马替尼布 (Imatinib) 的使用情况波纳提尼布 (ponatinib) 是一种没有进展,没有进展.减少强度化疗的化疗.更多相关视频
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.5K
10:49Pre-clinical Evaluation of Tyrosine Kinase Inhibitors for Treatment of Acute Leukemia
Published on: September 18, 2013
18.2K
相关概念视频
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:49Cancer Therapies
7.7K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.7K